metolazone

Generic: metolazone

Labeler: mylan institutional inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metolazone
Generic Name metolazone
Labeler mylan institutional inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

metolazone 2.5 mg/1

Manufacturer
Mylan Institutional Inc.

Identifiers & Regulatory

Product NDC 51079-023
Product ID 51079-023_3a866716-12c7-4380-e063-6394a90ae975
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076698
Listing Expiration 2026-12-31
Marketing Start 2005-04-15

Pharmacologic Class

Established (EPC)
thiazide-like diuretic [epc]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51079023
Hyphenated Format 51079-023

Supplemental Identifiers

RxCUI
197979 311671
UNII
TZ7V40X7VX
NUI
N0000175359 N0000175420

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metolazone (source: ndc)
Generic Name metolazone (source: ndc)
Application Number ANDA076698 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (51079-023-20) / 1 TABLET in 1 BLISTER PACK (51079-023-01)
source: ndc

Packages (1)

51079-023-20 100 BLISTER PACK in 1 CARTON (51079-023-20) / 1 TABLET in 1 BLISTER PACK (51079-023-01)

Ingredients (1)

metolazone (2.5 mg/1)

Linked Drug Pages (1)

Metolazone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a866716-12c7-4380-e063-6394a90ae975", "openfda": {"nui": ["N0000175359", "N0000175420"], "unii": ["TZ7V40X7VX"], "rxcui": ["197979", "311671"], "spl_set_id": ["e5fe856e-7fd6-47fb-87f7-7c1c621f50a0"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (51079-023-20)  / 1 TABLET in 1 BLISTER PACK (51079-023-01)", "package_ndc": "51079-023-20", "marketing_start_date": "20050415"}], "brand_name": "Metolazone", "product_id": "51079-023_3a866716-12c7-4380-e063-6394a90ae975", "dosage_form": "TABLET", "pharm_class": ["Increased Diuresis [PE]", "Thiazide-like Diuretic [EPC]"], "product_ndc": "51079-023", "generic_name": "metolazone", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Metolazone", "active_ingredients": [{"name": "METOLAZONE", "strength": "2.5 mg/1"}], "application_number": "ANDA076698", "marketing_category": "ANDA", "marketing_start_date": "20050415", "listing_expiration_date": "20261231"}